Clinical trial
Safety and Effectiveness Using Pegasys and Copegus in Recipients of Liver…
NCT00275548 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00275548 |
|---|---|
| Title | Safety and Effectiveness Using Pegasys and Copegus in Recipients of Liver Transplantation With Hepatitis C |
| Official title | A Prospective, Randomized, Multi-center, Open-label, Comparative Safety and Efficacy Study of Prophylactically Administered Pegylated Interferon Alfa-2a(Pegasys) Plus Ribavirin vs. No Prophylaxis Following Liver Transplantation for Hepatitis C. |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | Roche Pharma AG Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Liver Transplant, Hepatitis C |
| Intervention type | Drug |
| Interventions | Pegasys, Copegus |
| Enrollment | 12 |
| Start date | Jul 1, 2004 |
| Primary completion | Jun 1, 2007 |
| Completion | Apr 1, 2009 |
| First posted | Jan 12, 2006 |
| Last update posted | Nov 11, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: